The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
Título
The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.
Autor
Rong Qiu, Jingwei Li, Yuxuan Xiao, Ziyi Gao, Yihang Weng, Qiran Zhang, Chengdi Wang, Hanlin Gong, Weimin Li
Descripción
Coronavirus disease 2019 (COVID-19) has spread almost all regions of the world and caused great loss to the whole body of mankind. Thus, numerous clinical trials were conducted to find specific medicine for COVID-19 recently. However, it remains unanswered whether they are beneficial. This study aimed to evaluate the efficiency and safety of the COVID-19 medicine. Studies were determined through searching PubMed, Embase, Cochrane Library, and Medline. The studies of COVID-19 medicine were involved with eligible end points containing mortality, discharge rate, rate of clinical improvement, and rate of serious adverse events. A total of 33 studies involving 37,879 patients were included in our study, whose intervening measures contained three major types of COVID-19 medicine, ACEI/ARB, antiviral medicine, and chloroquine/hydroxychloroquine. Compared to control group, COVID-19 drugs have no distinct effect on mortality (RR, 0.93; 95% CI, 0.79-1.11, P = .43) and discharge rate (RR, 1.06; 95% CI, 0.98-1.14, P = .13). However, antiviral medicine presents the obvious advantage in clinical improvement (RR, 1.11; 95% CI, 1.01-1.23, P < .05). In addition, the serious adverse events rate (RR, 0.75; 95% CI, 0.63-0.88, P < .05) of COVID-19 medicine is lower than control group. The results indicated antiviral medicine was potential specific medicine for COVID-19 treatment by improving clinical symptoms, but it failed to increase the discharge rate and reduce mortality. Chloroquine/hydroxychloroquine and ACEI/ARB had no significant effect on treatment of COVID-19, thus they were not recommended for routine medication. Moreover, more trials are needed to find effective drugs to lower the mortality of COVID-19 patients.
Fecha
2021
Identificador
10.1097/MD.0000000000025532
Fuente
Medicine
Colección
Citación
Rong Qiu, Jingwei Li, Yuxuan Xiao, Ziyi Gao, Yihang Weng, Qiran Zhang, Chengdi Wang, Hanlin Gong, Weimin Li, “The therapeutic effect and safety of the drugs for COVID-19: A systematic review and meta-analysis.,” SOCICT Open, consulta 18 de abril de 2026, https://www.socictopen.socict.org/items/show/6408.
Position: 13034 (22 views)